| 王倩,方英立,张莉,许懿,徐建江.临床药师参与1例化疗致药物性肝损伤患者的治疗实践[J].中国药事,2017,(2):197-200 |
| 临床药师参与1例化疗致药物性肝损伤患者的治疗实践 |
| Practice of Clinical Pharmacists Participating in the Treatment of a Case of Drug-induced Liver Injury during Chemotherapy |
| 投稿时间：2016-09-26 |
| DOI：10.16153/j.1002-7777.2017.02.016 |
| 中文关键词: 药物性肝损伤 临床药师 化疗药 药学监护 |
| 英文关键词: drug-induced liver injury clinical pharmacists chemotherapeutic agents pharmaceutical care |
| 基金项目: |
|
| 摘要点击次数: 885 |
| 全文下载次数: 497 |
| 中文摘要: |
| 目的：探讨临床药师在药物性肝损伤（DILI）患者药物治疗中的作用。方法：临床药师参与1例DILI患者治疗，分析药物和肝损伤的相关性，协助医师优化药物治疗方案，为患者提供全面的药学监护。结果：医师采纳临床药师建议，患者肝功能好转，本周期化疗顺利完成。结论：临床药师参与药学监护有助于临床合理用药，提高患者依从性，减少不良反应发生，确保患者用药安全。 |
| 英文摘要: |
| Objective: To discuss the role of clinical pharmacists in drug therapy for drug-induced liver injury (DILI) during chemotherapy.Methods: Clinical pharmacists participated in the therapy for a DILI patient during chemotherapy, analyzed the correlation between drug and liver injury, assisted doctors in optimizing drug therapy plan, and provided comprehensive pharmaceutical care for the patient.Results: The suggestion provided by clinical pharmacists was adopted by doctors, which helped the patient recover his liver function and guaranteed the successful execution of chemotherapy in the treatment.Conclusion: The participation of clinical pharmacists in pharmaceutical care can promote rational drug use in clinic, improve the patients' compliance, reduce the incidence of adverse drug reactions, and guarantee the safety of drug use. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|